Related Experiment Video
Updated: Jun 16, 2026

Detection of Alternative Splicing During Epithelial-Mesenchymal Transition
Published on: October 9, 2014
SOX2 modulates alternative splicing in transitional cell carcinoma
Chun-Liang Tung1, Pei-Hsuan Hou, Yung-Ling Kao
1Department of Pathology, Chia-Yi Christian Hospital, Chiayi, Taiwan.
Abstract:
Aberrant alternative splicing of key cellular regulators may play a pivotal role in cancer development. To investigate the potential influence of altered alternative splicing on the development of transitional cell carcinoma (TCC), splicing activity in the TCC cell lines TSGH8301 and BFTC905 was examined using the SV40-immortalized uroepithelial cell line SV-HUC-1 as a reference. Our results indicate a significant alteration in splice site selection in the TCC cell lines. By gene expression profiling and subsequent validation, we discovered that sex-determining region Y-box protein 2 (SOX2) is specifically upregulated in BFTC905. Furthermore, ectopic expression of SOX2 modulates alternative splicing of the splicing reporter in vivo. More significantly, using an in vitro pull-down assay, it was found that SOX2 exhibits RNA-binding capability. Our observations suggest that SOX2 modulates alternative splicing by functioning as a splicing factor.
Insights
Aberrant alternative splicing is implicated in cancer. This study reveals sex-determining region Y-box protein 2 (SOX2) acts as a splicing factor, modulating alternative splicing in transitional cell carcinoma (TCC).
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Aberrant alternative splicing of cellular regulators is linked to cancer development.
- Transitional cell carcinoma (TCC) is a significant form of cancer where splicing alterations may play a role.
Purpose of the Study:
- To investigate the influence of altered alternative splicing on TCC development.
- To identify specific splicing alterations and regulatory factors in TCC.
Main Methods:
- Splicing activity was examined in TCC cell lines (TSGH8301, BFTC905) and a reference uroepithelial cell line (SV-HUC-1).
- Gene expression profiling and validation were used to identify upregulated genes.
- In vivo splicing reporter assays and in vitro pull-down assays were performed.
Main Results:
- Significant alterations in splice site selection were observed in TCC cell lines.
- Sex-determining region Y-box protein 2 (SOX2) was found to be specifically upregulated in the BFTC905 TCC cell line.
- Ectopic SOX2 expression modulated alternative splicing, and SOX2 demonstrated RNA-binding capability, suggesting it functions as a splicing factor.
Conclusions:
- SOX2 plays a role in modulating alternative splicing in transitional cell carcinoma.
- SOX2's function as a splicing factor may contribute to TCC development.
- Targeting SOX2-mediated alternative splicing could be a potential therapeutic strategy for TCC.
Related Concept Videos
RNA Splicing
RNA Splicing
Alternative RNA Splicing
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
Alternative RNA Splicing
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
Pleiotropy
Chromatin Structure Regulates pre-mRNA Processing
The chromatin structure, especially...

